Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Variant AAV and compositions, methods and uses for gene transfer to cells, organs and tissues

Variant AAV and compositions, methods and uses for gene transfer to cells, organs and tissues

US Patent 9840719 · Granted Dec 12, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Optimized promoter sequences, intron-free expression constructs and methods of u2025
Codon-optimized acid alpha-glucosidase expression cassettes and methods of using2024
AAV vector compositions and methods for gene transfer to cells, organs and tissu2024
Modified factor IX, and compositions, methods and uses for gene transfer to cell2024
Modified factor IX, and compositions, methods and uses for gene transfer to cell2024
Scalable manufacturing platform for viral vector purification and viral vectors 2024
Large commercial scale lentiviral vector production system and vectors produced 2023
Compositions and methods for detection and modulation of T cell mediated immune 2023
Modified factor IX, and compositions, methods and uses for gene transfer to cell2022
Modified factor IX, and compositions, methods and uses for gene transfer to cell2022
AAV vector and assay for anti-AAV (adeno-associated virus) neutralizing antibodi2022
Composition and methods for highly efficient gene transfer using AAV capsid vari2022